CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8
Clinical trials for CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Drug combo shows promise against brain metastases in melanoma
Disease control CompletedThis study tested a combination of two immunotherapy drugs (low-dose ipilimumab and pembrolizumab) in 24 people with advanced melanoma that had spread to the brain. The goal was to see if the treatment could shrink or control brain tumors and improve survival. Participants receiv…
Matched conditions: CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
Lower chemo dose shows promise in melanoma cell therapy trial
Disease control CompletedThis study tested a treatment for advanced melanoma that cannot be removed by surgery or has spread. It used a lower dose of chemotherapy followed by infusion of the patient's own immune cells (lifileucel) grown from their tumor. The goal was to see if this approach is safe and h…
Matched conditions: CLINICAL STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 01, 2026 15:26 UTC